Biocence

Biocence is a topical antiseptic manufactured and sold by BGP, LLC in Los Angeles, California, USA. Biocence is a non-alcohol, all-botanical (green), antimicrobial, botanical-drug. Biocence has been registered with the FDA as a Category I OTC Topical Antiseptic. Evidence-based antimicrobial study data from independent laboratories has demonstrated the effectiveness of Biocence in prophylaxis/prevention and the assistance in mitigation and eradication of the pathological effects in pathogenic microbial entities.
Biocence OTC Topical Antiseptic is currently sold worldwide and the BBC (Biocence Botanical Complex) is used in a variety of products as a stand-alone preservative system, approved by the PCPC (Personal Care Product Council). The BBC is a paraben and formaldehyde-free, botanical complex used in the personal care, OTC and toiletry industries.
History
Allan Lord, developed the present formulation of Biocence in 2006 in Los Angeles, California. His research and interest in the regenerative properties of natural hydrocarbon components led to his experimentation with organic substance entities: ie, flavonoids, flavanoids and terpenoids. During his years of extensive research he delved deeply into understanding the use of flavonoids and terpenoids in protecting plants and herbs from bacteria, fungi and viruses. Lord eventually concluded that by using a specific combination of “nature’s anti-nutrient protective organic bio-chemicals,” humans and animals could be protected from microbial infections; furthermore, they could be treated with this complex which could help eradicate pathogens that cause significant human and animal morbidities and death.
From 1995-2010, university and independent clinical studies verified that Lord’s formulas were able to successfully eradicate over 800 pathogens and “opportunistic pathogens,” involving bacteria, multi-cellular and uni-cellular fungi and viruses.
In 2007, at an FDA certified and licensed laboratory in Los Angeles, CA., it was repetitively verified that the BBC was able to eradicate, on contact or in less than 30 seconds, numerous emerging “superbugs,” ie: MRSA strains, Proprionibacter acne, Acinetobacter spp, Escherichia coli and developing virulent strains, Enterococcus faecalis, H1N1, Candida spp, Aspergillus, Pseudomonas spp, Salmonella spp, Mycobacteria spp. and many others.
To date, the BBC has shown “no microbial resistance” in studies done by independent FDA licensed Bacterium and Virucidal OTC certified laboratories. The clinical R.I.P.T. (Repeat Insult Patch Tests) with the BBC, applied in all ages, both genders and all ethnic groups, has demonstrated 100% non-irritability to epithelial surfaces.
Technology
The BBC based preservative system is an all-botanical flavonoid/flavanoid/terpenoid complex. Its pan-antimicrobial properties have been demonstrated in third-party, level 2 & 3 microbiological laboratories over the past 10 years. The Biocence Botanical Complex technology's effectiveness in trans-taxonomic domains (Prokaryote and Eukaryote) and the “Viral Kingdom,” have been clinically shown to prevent and treat the escalating pandemics of pharmaceutical drug-resistant microbes.
Method of Action and Effectiveness
The lack of microbial resistance to the Biocence Botanical Complex, creates a very plausible and scientifically-supported supposition of the pan-antimicrobial “cidal” activities in the Complex. In the mid-20th Century, Royal Rife, American Inventor (Vibratory Medicine; Dr. James Oschman, “Energy medicine: The Scientific Basis;” Barry Lynes, “The Cancer Cure That Worked”), demonstrated through exhaustive study and data accumulation, that ALL organic and inorganic structures have an inherent “Coordinative Frequency,” and all organic molecular entities have a specific “Mortal Oscillatory Rate.” It is with these data that the modern scientific field of Vibrational Energy Medicine was introduced. The Taxonomic Trans-Domain (Prokaryote and Eukaryote) and Viral Kingdom Antimicrobial “Cidal” effectiveness of the Biocence Botanical Complex creates a very strong supportive supposition of the mortal oscillatory rate (MOR) pan-antimicrobial foundation of the BBC’s “cidal activities.”
Whereas synthetic, pharmaceutical antimicrobial drugs are created with a finite, reductionistic focus on a specific, metabolic cascade interruption or receptor agonism or antagonism, these antimicrobial effects create a platform for rapid genomic expressive secondary to epigenetic modulations and the resultant, antimicrobial-drug resistant organism. With the recognized Bacterial (Prokaryote), Fungal (Eukaryote) and Viral Kingdom “cidal” activities, and with the majority of pathogenic, microbes dying “on contact,” but all within 30 seconds, no other plausible and scientifically supported Method of Action has been found to explain this multi-domain and viral kingdom antimicrobial effectiveness. The broad-spectrum of vibrational or oscillatory frequencies within the BBC, creates a “Universal MOR” for pathogenic microbes, while creating an environment of healing and metabolic support for both non-pathogenic endothelial and epithelial tissue.
Active Ingredients
Biocence active ingredients include natural and organic oils and raw materials of Eucalyptus, Thyme, Wintergreen, Peppermint, Rosemary, Tea Tree, and other natural oils. This proprietary complex of ingredients is based on a balanced composite of hydrocarbon flavonoid/flavanoid and terpenoid components, mixed into an emollient base for optimal preservation.
Production
Biocence is produced and manufactured exclusively in Los Angeles California USA, by BGP, LLC.
Safety
Biocence is an efficacious, safe, 100 % “All-Botanical,” Category I OTC Topical Antiseptic and a CTFA (Cosmetic, Toiletry and Fragrance Assoc.), approved, “stand alone, and green preservative system. The Biocence Botanical Complex has a G.R.A.S.E. (Generally Recognized As Safe and Effective) status by the FDA.

Main Menu

See Also

Main Menu